Quick Takeaways
- Jeff E. Knight has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,222,088.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jeff E. Knight
- Location
- San Diego, CA
- Summary
- The estimated net worth of Jeff E. Knight is at least $4,222,088 dollars as of 17 Apr 2026. Jeff E. Knight is the Chief Dev. & Operating Officer of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $4.22M.
- Signature
- /s/ Shelly Wong, by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jeff E. Knight and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Crinetics Pharmaceuticals, Inc. ($4,222,088).
- Past-year value change for that position: -$3,785,448.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jeff E. Knight
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | Chief Dev. & Operating Officer | $4,222,088 | -$3,785,448 | -47% | 08 Apr 2026 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Chief Dev & Operating Officer | 16 Apr 2026 |
Insider Transactions Reported by Jeff E. Knight:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.